August 2016 Preclincal Pathfinder recently completed a promising PK study for MAA laboratories. Subsequently, Preclinical Pathfinder and MAA laboratories ( North Carolina) have now entered into an agreement that Pathfinder will conduct all preclinical research for MAA laboratories.
Read More
July 2016 Francis Chester, Preclinical Pathfinder’s VP of Government Contracts, was elected Chairman of the North Carolina Defense Business Association (NCDBA). The NCDBA consists of over 250 defense contractors, community and business leaders from across the state as well as military leadership. It’s an organization that focuses on improving the economic environment to enhance businesses […]
Read MoreJuly 8th 2016 Preclinical Pathfinder and Duke Preclinical Translational Research Unit teamed with the NJ Institution of Innovation and other pharmaceutical industry and academic institutions to establish The Innovative Medicines Manufacturing Institute (IMMI). Our goal is to obtain a 70 million dollar grant to assist bio-pharmaceutical companies, regulatory agencies, and technology suppliers in addressing the need for […]
Read MoreJune 2016 Preclinical Pathfinder and Araim Pharmaceutical ( New York) entered into an agreement to start preclinical development for a new cancer therapy.
Read MoreAllan Reisss joined Preclinical Pathfinder as COO, Allan was the president of … for more than …… Allan extensive experience in .. . we are excited for Allan to join us.
Read MoreAllan joins Preclinical Pathfinder as COO. Allan bring extensive experience having spent more than 15 years in leadership roles in the preclinical and life sciences industry.
Read More